-
Does psilocybin increase synaptic density in the brain in patients with mild cognitive impairment?
https://braincanada.ca/fr/subventions-financées/does-psilocybin-increase-synaptic-density-in-the-brain-in-patients-with-mild-cognitive-impairmentAmnestic mild cognitive impairment (aMCI) is viewed as a precursor to Alzheimer’s Disease (AD) for which there are no effective treatments. Project Overview Amnestic mild cognitive impairment (aMCI) is viewed as a precursor to Alzheimer’s Disease (AD) for which there are no effective treatments....
-
Does rehabilitation improve brain structure/function and motor outcomes of children with developmental coordination disorder?
https://braincanada.ca/fr/subventions-financées/does-rehabilitation-improve-brain-structure-function-and-motor-outcomes-of-children-with-developmental-coordination-disorderMs. Izadi-Najafabadi’s research focuses on the effect of Cognitive Orientation to Occupational Performance (CO-OP)—the current best-practiced intervention for children with Developmental Coordination Disorder (DCD)—on their structural and functional brain connectivity. Project Overview Ms....
-
Does the Epstein-Barr virus activate immune cells before multiple sclerosis becomes symptomatic?
https://braincanada.ca/fr/subventions-financées/does-the-epstein-barr-virus-activate-immune-cells-before-multiple-sclerosis-becomes-symptomaticMultiple Sclerosis (MS) is a serious chronic neurological condition, particularly common among young adults in Canada. Project Overview Multiple Sclerosis (MS) is a serious chronic neurological condition, particularly common among young adults in Canada. The exact cause of MS is unknown, but it...
-
Dopamine modulation of neural circuits in the amygdala
https://braincanada.ca/fr/subventions-financées/dopamine-modulation-of-neural-circuits-in-the-amygdalaMotivated, goal-directed behaviours exist to sustain life and permit both humans and animals to learn to navigate the world while pursuing rewards and avoiding threats and punishment. Project Overview Motivated, goal-directed behaviours exist to sustain life and permit both humans and animals to...
-
Dopaminergic modulation of stroke recovery
https://braincanada.ca/fr/subventions-financées/dopaminergic-modulation-of-stroke-recoveryStrokes often cause brain damage that affects normal cognitive and sensorimotor functions. Project Overview Strokes often cause brain damage that affects normal cognitive and sensorimotor functions. The brain has the extraordinary ability to adapt by forming new circuits which can, to some extent,...
-
Douglas-Bell Canada Brain Bank, an essential platform for brain research in Canada
https://braincanada.ca/fr/subventions-financées/douglas-bell-canada-brain-bank-an-essential-platform-for-brain-research-in-canadaThe Douglas-Bell Canada Brain Bank (DBCBB) houses and manages over 3,000 brains, as well as a large relational database containing demographic, clinical and developmental histories from the donors. Project Overview The Douglas-Bell Canada Brain Bank (DBCBB) houses and manages over 3,000 brains, as...
-
Dr Alex Parker : La lutte contre le « problème difficile » de la SLA ne sera pas abandonnée
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/ne-pas-abandonner-le-difficile-problème-de-l-alsLe Dr Alex Parker, du Centre de recherche du CHUM, Université de Montréal, est l'un des deux premiers récipiendaires de la nouvelle subvention à la découverte SLA Canada-Cerveau Canada, d'une durée de trois ans et d'un montant de 300 000 $. La bourse du Dr Parker a été financée grâce à un généreux...
-
Dr Carlos Rodrigo Camara-Lemarroy : Raccourcir les délais pour des traitements accessibles et traduisibles de SLA
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/raccourcir-les-délais-pour-les-traitements-alsLe Dr Carlos Rodrigo Camara-Lemarroy est un chercheur en début de carrière et un neurologue clinicien basé au Canada, à l’Université de Calgary. Il est bénéficiaire pour la première fois de la bourse de recherche de la Société canadienne de la SLA et de la Fondation Brain Canada. Cette procédure...
-
Dr Gary Shaw : Explorer comment les cellules « sortent les déchets » pour trouver de nouvelles cibles thérapeutiques dans la SLA
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/trouver-de-nouvelles-cibles-thérapeutiques-dans-l-alsGary Shaw est biochimiste à l'Université Western et l'un des neuf récipiendaires d'une subvention à la découverte de SLA Canada-Cerveau Canada pour 2022. "C'est toujours très excitant d'obtenir une subvention de recherche, parce qu'on utilise les idées qu'on a trouvées dans la littérature et autour...
-
Dr. Hubert van Tol Travel Fellowship
https://braincanada.ca/fr/subventions-financées/dr-hubert-van-tol-travel-fellowship-13Sofia Gentile, a Master’s Student at University of Toronto, is investigating the role of immune cell activation in a rare and fatal neurodegenerative disease called progressive supranuclear palsy. Project Overview Sofia Gentile, a Master’s Student at University of Toronto, is investigating the role...